PL372450A1 - Preparaty lecznicze zawierające leki betamimetyczne i nowy lek antycholinoesterazowy - Google Patents

Preparaty lecznicze zawierające leki betamimetyczne i nowy lek antycholinoesterazowy

Info

Publication number
PL372450A1
PL372450A1 PL03372450A PL37245003A PL372450A1 PL 372450 A1 PL372450 A1 PL 372450A1 PL 03372450 A PL03372450 A PL 03372450A PL 37245003 A PL37245003 A PL 37245003A PL 372450 A1 PL372450 A1 PL 372450A1
Authority
PL
Poland
Prior art keywords
medicaments containing
novel
anticholinesterase drug
betamimetic
drugs
Prior art date
Application number
PL03372450A
Other languages
English (en)
Other versions
PL213489B1 (pl
Inventor
Rolf Banholzer
Christopher John Montague Meade
Helmut Meissner
Gerd Morschhäuser
Michel Pairet
Michael P. Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Ingo Konetzki
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10256317A external-priority patent/DE10256317A1/de
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL372450A1 publication Critical patent/PL372450A1/pl
Publication of PL213489B1 publication Critical patent/PL213489B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
PL372450A 2002-04-12 2003-04-09 Kompozycje farmaceutyczne zawierajace betamimetyk i nowy lek antycholinergiczny oraz zastosowanie kompozycji PL213489B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (de) 2002-04-12 2002-12-03 Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum

Publications (2)

Publication Number Publication Date
PL372450A1 true PL372450A1 (pl) 2005-07-25
PL213489B1 PL213489B1 (pl) 2013-03-29

Family

ID=29251756

Family Applications (1)

Application Number Title Priority Date Filing Date
PL372450A PL213489B1 (pl) 2002-04-12 2003-04-09 Kompozycje farmaceutyczne zawierajace betamimetyk i nowy lek antycholinergiczny oraz zastosowanie kompozycji

Country Status (19)

Country Link
EP (1) EP1497289B1 (pl)
JP (1) JP2005529111A (pl)
CN (1) CN1646527A (pl)
AT (1) ATE302774T1 (pl)
AU (1) AU2003232201B2 (pl)
BR (1) BR0309185A (pl)
CA (1) CA2481468C (pl)
DK (1) DK1497289T3 (pl)
ES (1) ES2248767T3 (pl)
HR (1) HRP20040944B1 (pl)
IL (1) IL164291A (pl)
MX (1) MXPA04009916A (pl)
NO (1) NO20044107L (pl)
NZ (1) NZ536337A (pl)
PL (1) PL213489B1 (pl)
PT (1) PT1497289E (pl)
RS (1) RS50735B (pl)
UY (1) UY27757A1 (pl)
WO (1) WO2003087097A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7244728B2 (en) 2004-03-17 2007-07-17 Boehringer Ingelheim International Gmbh Long acting betamimetics for the treatment of respiratory diseases
EP1577306A1 (de) * 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
EP1850831B1 (en) 2005-02-25 2015-12-02 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
JP2009504624A (ja) 2005-08-08 2009-02-05 アージェンタ ディスカバリー リミテッド ビシクロ[2.2.1]ヘプタ−7−イルアミン誘導体およびその使用
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
CN116036425A (zh) 2014-05-07 2023-05-02 勃林格殷格翰国际有限公司 喷雾器、指示器装置及容器
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
PT1497289E (pt) 2005-11-30
CN1646527A (zh) 2005-07-27
PL213489B1 (pl) 2013-03-29
NO20044107L (no) 2004-11-04
EP1497289A1 (de) 2005-01-19
JP2005529111A (ja) 2005-09-29
IL164291A0 (en) 2005-12-18
DK1497289T3 (da) 2005-10-24
RS89804A (sr) 2006-10-27
WO2003087097A1 (de) 2003-10-23
MXPA04009916A (es) 2005-05-03
AU2003232201A1 (en) 2003-10-27
UY27757A1 (es) 2003-11-28
NZ536337A (en) 2007-05-31
ATE302774T1 (de) 2005-09-15
ES2248767T3 (es) 2006-03-16
EP1497289B1 (de) 2005-08-24
HRP20040944B1 (en) 2012-12-31
CA2481468A1 (en) 2003-10-23
CA2481468C (en) 2011-02-01
IL164291A (en) 2012-04-30
HRP20040944A2 (en) 2005-04-30
AU2003232201B2 (en) 2009-06-11
RS50735B (sr) 2010-08-31
BR0309185A (pt) 2005-02-15

Similar Documents

Publication Publication Date Title
IL164291A0 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
WO2004037807A3 (en) Medicinal arylethanolamine compounds
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
ATE420632T1 (de) Titrationsdosierschema für kontrolliert freigesetztes tramadol
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
WO2007117509A8 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
FI990914A0 (fi) Jauheinhalaattori yhdistelmälääkkeelle
UA86977C2 (ru) Производные гидантоина для лечения обструктивных болезней дыхательных путей
MXPA03009849A (es) Uso de azitromicina para la fabricacion de un medicamento para el tratamiento de enfermedades inflamatorias no infecciosas.
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
PL1643999T3 (pl) Pirydoksamina do zastosowania w leczeniu nefropatii cukrzycowej w cukrzycy typu II
Plantevin et al. Effect of mandibular nerve block on postoperative analgesia in patients undergoing oropharyngeal carcinoma surgery under general anaesthesia
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
DE602004019096D1 (de) Medikamente zur inhalation mit betamimetika und einem anticholinergikum
MXPA02009603A (es) Terapias de dosis divididas con actividad de deterioro vascular.
UY26990A1 (es) Nuevas composiciones de medicamentos

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130409